Ozren Jakšić

University of Zagreb — Croatia

Medicine · Health Sciences

25h-index3.0kcitations208works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Lymphocytic Leukemia Research(87), Lymphoma Diagnosis and Treatment(52), COVID-19 Clinical Research Studies(19), Chronic Myeloid Leukemia Treatments(19), Multiple Myeloma Research and Treatments(17)

Publications206 total

The effect of doping, anti-doping measures, and sociological factors on the annual distribution of all-time top performances in short, middle, and long-distance running
Frontiers in Sports and Active Living·2025Open Access
Addressing cardiovascular toxicities of Bruton tyrosine kinase inhibitors in chronic lymphocytic leukaemia: practical recommendations for haematologists in central and eastern Europe
Cardio-Oncology·2025Open Access
Survival differences of patients with treatment-naive CLL between the chemoimmunotherapy and BTKi eras: An eric study.
Blood·2025
Central nervous system involvement in CLL: an international retrospective study by ERIC, the European Research Initiative on CLL
Blood Advances·2025Open Access
POSTER: MM-1078 Predictors of Thrombotic Risk in Patients With Newly Diagnosed Multiple Myeloma Treated From 2016 to 2023
Clinical Lymphoma Myeloma & Leukemia·2025
MM-1078: Predictors of Thrombotic Risk in Patients With Newly Diagnosed Multiple Myeloma Treated From 2016 to 2023
Clinical Lymphoma Myeloma & Leukemia·2025
ABCL-361: Time-Limited Antithrombotic Prophylaxis Reduces the Risk of PICC-Related Thrombosis in Patients With Aggressive B-Cell Lymphoma Receiving DA-EPOCH-R
Clinical Lymphoma Myeloma & Leukemia·2025
POSTER: ABCL-361 Time-Limited Antithrombotic Prophylaxis Reduces the Risk of PICC-Related Thrombosis in Patients With Aggressive B-Cell Lymphoma Receiving DAEPOCH-R
Clinical Lymphoma Myeloma & Leukemia·2025
Practical Management of Cardiovascular Adverse Events with BTKi Treatment in Patients with Chronic Lymphocytic Leukemia: A Consensus Report by Hematologists and Cardiologists
Acta Haematologica·2025Open Access
Efficacy, Toxicity and Effect of Pretreatment Cardiologic Consultation on Outcomes of Ibrutinib Therapy for Chronic Lymphocytic Leukemia—A KroHem Study
Cancers·2025· 1 citedOpen Access
Obinutuzumab in Combination with Alternative Chlorambucil Schedules in Front-Line Treatment of Chronic Lymphocytic Leukemia: A Study by KroHem, the Croatian Cooperative Group for Hematologic Diseases
Biomedicines·2024Open Access
Plateletcrit and the Risk of Bleeding in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated with Bruton's Tyrosine Kinase Inhibitors
Blood·2024
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL
HemaSphere·2024· 1 citedOpen Access
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
Infection·2024Open Access
HODGKINOV LIMFOM - USMENO IZLAGANJE
Liječnički vjesnik·2024· 1 citedOpen Access
VENSKE TROMBOZE I TROMBOFILIJA - USMENO IZLAGANJE
Liječnički vjesnik·2024Open Access
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry
Haematologica·2024· 7 citedOpen Access
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
EClinicalMedicine·2024· 29 citedOpen Access
Athlete biological passport: longitudinal biomarkers and statistics in the fight against doping
Archives of Industrial Hygiene and Toxicology·2024· 4 citedOpen Access
Secondary polycythemia in acutely ill COVID-19 patients is associated with higher mortality but not markedly higher thrombotic risk
Scandinavian Journal of Clinical and Laboratory Investigation·2024· 1 cited
page 1 of 11Next →

Frequent Co-authors

Alberto López‐García(14), Raúl Córdoba(13), Monia Marchetti(12), María Gomes da Silva(12), Andreas Glenthøj(12), Raquel Nunes Rodrigues(12), Jon Salmanton‐García(11), Francesco Marchesi(11), Rafael F. Duarte(11), Barbora Weinbergerová(10), Chiara Cattaneo(10), Jaap A. van Doesum(10), Ola Blennow(10), Iker Falces‐Romero(10), José‐Ángel Hernández‐Rivas(10), Jorge Labrador(10), Rajko Kušec(10), Livio Pagano(9), Alessandro Busca(9), Federico Itri(9)